ERK1/2 gene expression and hypomethylation of Alu and LINE1 elements in patients with type 2 diabetes with and without cataract: Impact of hyperglycemia‐induced oxidative stress
Journal of Diabetes Investigation · 2025
DOI: 10.1111/jdi.14405 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2025. Verfasst von Elham Zeinali Nia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Basic Sciences, Islamic Azad University Damghan Branch, Damghan, Iran. Hauptthemen laut MEDLINE: Cataract, Diabetes Mellitus, Type 2, Oxidative Stress, DNA Methylation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
This study aimed to delineate the effect of hyperglycemia on the Alu/LINE‐1 hypomethylation and in ERK1/2 genes expression in type 2 diabetes with and without cataract.
Methods
This study included 58 diabetic patients without cataracts, 50 diabetic patients with cataracts, and 36 healthy controls. After DNA extraction and bisulfite treatment, LINE‐1 and Alu methylation levels were assessed using Real‐time MSP. ERK1/2 gene expression was analyzed through real‐time PCR. Total antioxidant capacity (TAC), and fasting plasma glucose (FPG) were measured using colorimetric methods. Statistical analysis was performed with SPSS23, setting the significance level at P < 0.05.
Results
The TAC levels were significantly lower for cataract and diabetic groups than controls (259.31 ± 122.99, 312.43 ± 145.46, 372.58 ± 132.95 nanomole of Trolox equivalent) with a significant correlation between FPG and TAC levels in both the cataract and diabetic groups ( P < 0.05). Alu and LINE‐1 sequences were found to be statistically hypomethylated in diabetic and cataract patients compared to controls. In these groups, TAC levels were directly correlated with Alu methylation ( P < 0.05) but not LINE‐1. ERK1/2 gene expression was significantly higher in diabetic and cataract patients, showing increases of 2.41‐fold and 1.43‐fold for ERK1, and 1.27‐fold and 1.5 for ERK2, respectively. ERK1 expression correlated significantly with FPG levels. A reverse correlation was observed between TAC levels and ERK1/2 expression.
Conclusions
Our findings indicate that hyperglycemia‐induced oxidative stress may alter ERK1/2 gene expression patterns and induce aberrant hypomethylation in Alu and LINE‐1 sequences. These aberrant changes may play a contributing role in diabetic complications such as cataracts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Basic Sciences, Islamic Azad University Damghan Branch, Damghan, Iran.
- Department of Clinical Biochemistry, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
- Department of Medical Sciences, Shahid Beheshti University, Tehran, Iran.
ORCID-Profile: Ruhollah Najjar Sadeghi
Zitieren
APA
Zeinali Nia, E., Najjar Sadeghi, R., Ebadi, M., & Faghihi, M. (2025). ERK1/2 gene expression and hypomethylation of Alu and LINE1 elements in patients with type 2 diabetes with and without cataract: Impact of hyperglycemia‐induced oxidative stress. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14405
Vancouver
Zeinali Nia E, Najjar Sadeghi R, Ebadi M, Faghihi M. ERK1/2 gene expression and hypomethylation of Alu and LINE1 elements in patients with type 2 diabetes with and without cataract: Impact of hyperglycemia‐induced oxidative stress. Journal of Diabetes Investigation. 2025. doi:10.1111/jdi.14405
BibTeX
@article{ZeinaliNia2025,
author = {Zeinali Nia, Elham and Najjar Sadeghi, Ruhollah and Ebadi, Mostafa and Faghihi, Mohammad},
title = {ERK1/2 gene expression and hypomethylation of Alu and LINE1 elements in patients with type 2 diabetes with and without cataract: Impact of hyperglycemia‐induced oxidative stress},
journal = {Journal of Diabetes Investigation},
year = {2025},
doi = {10.1111/jdi.14405}
}
EUVIMED